# Feds Award $6.5M Grant to Support Developing Cannabis Withdrawal Treatment > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/feds-award-6-5m-grant-to-support-developing-cannabis-withdrawal-treatment/ > **Published:** 2026-08-23T07:41:56-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:26:58-04:00 > **Clinical Summary:** Learn about the $6.5M federal grant supporting Phase 3 trials for cannabis withdrawal treatment, advancing clinical evidence in this critical area. --- ✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchMental HealthNeurologyDosingSafetyPain Why This Matters This grant for developing cannabis withdrawal treatment is significant for clinicians as it could lead to the creation of effective treatments for patients dealing with cannabis dependency. The advancement in clinical evidence may provide healthcare professionals with new tools to address substance use disorders more effectively, thereby improving [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and outcomes. Clinical Summary This $6.5M grant supports a pivotal Phase 3 program aimed at developing cannabis withdrawal treatment. The clinical evidence generated from this research could potentially improve management strategies for patients experiencing [cannabis dependence](https://cedclinic.com/ptsd-cannabis-dependence-veterans-social-support/), offering enhanced care options in the future. Dr. Caplan’s Take “As a family physician with two decades of experience in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), I am encouraged by this grant supporting the development of withdrawal treatment. While it’s crucial to acknowledge that more research is needed to fully understand the efficacy and safety of these treatments, this funding will help us move closer to providing evidence-based solutions for those struggling with cannabis dependency.” Clinical Perspective 🔬 A significant $6.5M grant for developing cannabis withdrawal treatment marks a promising step forward in addressing the complexities of marijuana dependence. While acknowledging the need for further research to account for individual variability, comorbidities, and potential interactions with other substances, this funding could potentially lead to evidence-based treatments for [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/). In clinical practice, healthcare providers may soon have additional tools to assist patients struggling with cannabis addiction, ultimately improving overall [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) outcomes. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Feds%20Award%20%246.5M%20Grant%20to%20Support%20Developing%20Cannabis%20Withdrawal%20Treatment%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74654)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74654)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Feds%20Award%20%246.5M%20Grant%20to%20Support%20Developing%20Cannabis%20Withdrawal%20Treatment%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74654)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [PleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for …](https://cedclinic.com/pleopharma-awarded-6-5-million-nida-grant-to-support-phase-3-trial-of-pp-01-for/) - Grassy Narrows First Nation Denied Federal Funding for Residential School Search - [India Issues First Cannabis Research Grant That Could Help Open Up Market](https://cedclinic.com/india-cannabis-research-grant-medical-market/) 📰 Source: [https://www.cannabisequipmentnews.com/news/news/22972851/feds-award-65m-grant-to-support-developing-cannabis-withdrawal-treatment](https://www.cannabisequipmentnews.com/news/news/22972851/feds-award-65m-grant-to-support-developing-cannabis-withdrawal-treatment) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).